Connection

Andrew Ward to HIV Antibodies

This is a "connection" page, showing publications Andrew Ward has written about HIV Antibodies.
Connection Strength

3.611
  1. Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization. Sci Adv. 2021 07; 7(31).
    View in: PubMed
    Score: 0.573
  2. The 2017 Keystone Symposium on HIV Vaccines. Hum Vaccin Immunother. 2017 10 03; 13(10):2348-2351.
    View in: PubMed
    Score: 0.439
  3. Time-course, negative-stain electron microscopy-based analysis for investigating protein-protein interactions at the single-molecule level. J Biol Chem. 2017 11 24; 292(47):19400-19410.
    View in: PubMed
    Score: 0.439
  4. Playing Chess with HIV. Immunity. 2019 02 19; 50(2):283-285.
    View in: PubMed
    Score: 0.121
  5. Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens. J Pharm Sci. 2019 07; 108(7):2264-2277.
    View in: PubMed
    Score: 0.121
  6. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization. Immunity. 2018 08 21; 49(2):288-300.e8.
    View in: PubMed
    Score: 0.116
  7. Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity. Nat Commun. 2018 02 28; 9(1):877.
    View in: PubMed
    Score: 0.113
  8. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog. 2018 02; 14(2):e1006913.
    View in: PubMed
    Score: 0.113
  9. Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response. Vaccine. 2018 03 14; 36(12):1627-1636.
    View in: PubMed
    Score: 0.113
  10. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. J Proteome Res. 2018 03 02; 17(3):987-999.
    View in: PubMed
    Score: 0.113
  11. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers. J Biol Chem. 2018 02 02; 293(5):1688-1701.
    View in: PubMed
    Score: 0.111
  12. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates. J Virol. 2017 11 01; 91(21).
    View in: PubMed
    Score: 0.110
  13. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Rep. 2017 Oct 03; 21(1):222-235.
    View in: PubMed
    Score: 0.110
  14. Targeted N-glycan deletion at the receptor-binding site retains HIV Env NFL trimer integrity and accelerates the elicited antibody response. PLoS Pathog. 2017 Sep; 13(9):e1006614.
    View in: PubMed
    Score: 0.109
  15. Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers. Sci Rep. 2017 08 21; 7(1):8390.
    View in: PubMed
    Score: 0.109
  16. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity. 2017 06 20; 46(6):1073-1088.e6.
    View in: PubMed
    Score: 0.108
  17. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop. Immunity. 2017 05 16; 46(5):777-791.e10.
    View in: PubMed
    Score: 0.107
  18. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic ß-Hairpin Structure. Immunity. 2017 04 18; 46(4):690-702.
    View in: PubMed
    Score: 0.106
  19. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. PLoS Pathog. 2017 01; 13(1):e1006074.
    View in: PubMed
    Score: 0.104
  20. The HIV-1 envelope glycoprotein structure: nailing down a moving target. Immunol Rev. 2017 01; 275(1):21-32.
    View in: PubMed
    Score: 0.104
  21. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer. Nat Commun. 2018 09 12; 9(1):3693.
    View in: PubMed
    Score: 0.029
  22. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro. J Virol. 2018 07 01; 92(13).
    View in: PubMed
    Score: 0.029
  23. Structure of a cleavage-independent HIV Env recapitulates the glycoprotein architecture of the native cleaved trimer. Nat Commun. 2018 05 16; 9(1):1956.
    View in: PubMed
    Score: 0.029
  24. Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. PLoS Pathog. 2018 05; 14(5):e1006986.
    View in: PubMed
    Score: 0.029
  25. High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers. J Virol. 2017 11 15; 91(22).
    View in: PubMed
    Score: 0.028
  26. Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes. J Biol Chem. 2017 09 22; 292(38):15849-15858.
    View in: PubMed
    Score: 0.027
  27. Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers. J Virol. 2017 08 01; 91(15).
    View in: PubMed
    Score: 0.027
  28. Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. J Virol. 2017 06 15; 91(12).
    View in: PubMed
    Score: 0.027
  29. Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein. Immunity. 2017 05 16; 46(5):792-803.e3.
    View in: PubMed
    Score: 0.027
  30. Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12. Cell Rep. 2013 Dec 12; 5(5):1443-55.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.